EUVIMEDEUVIMED entdecken
Crossref

Classic Desmoplastic Ameloblastoma: Should It Be a Distinct Subtype of Ameloblastoma?—Based on Clinicopathological, Radiological, Immunohistochemical and Molecular Study of a Large Cohort

Xiaofeng Zheng, Ronghui Xia iD, Wenjing Zhu, Chuxiang Qu, Ting Gu, Liam Robinson iD, Willie van Heerden iD, Wanninayake Mudiyanselage Tilakaratne iD, Kelly Magliocca iD, Merva Soluk-Tekkesin iD, Akinyele Olumuyiwa Adisa iD, Elizabeth Ann Bilodeau iD und 5 weitere

Oral Diseases · 2025

DOI: 10.1111/odi.15376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Xiaofeng Zheng und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Pathology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, C…. Hauptthemen laut MEDLINE: Ameloblastoma, Mandibular Neoplasms, Jaw Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Shanghai's Top Priority Research Center, Cross-research Fund Project of Shanghai Ninth People's Hospital and Shanghai University of Science and Technology, National Clinical Medical Research Center for Oral Diseases (Shanghai Ninth Hospital).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To identify whether the classic desmoplastic ameloblastoma (DA) is an independent subtype of ameloblastoma. Materials and Methods Eighty‐six classic DA and 28 hybrid DA cases were retrieved, and available clinical, radiological, and histopathological data were collected. DNA from microdissected tumor tissues were utilized for BRAF V600E , SMOL412F , and CTNNB1 mutation detection. Data of classic DA and hybrid DA were analyzed and compared with each other and with previous reports of conventional ameloblastoma (CA).

Results

69.8% (60/86) of classic DA occurred in the mandible, with the majority affecting the anterior‐premolar regions. They were characterized as osteolytic bone expansion (33.8 ± 12.8 mm) with internal bone/calcification (57/58, 98.3%) in radiology. Genetically, classic DA exhibited a high incidence of BRAF V600E mutation (58/62, 93.5%) but no CTNNB1 and SMO L412F mutations. Hybrid DA exhibited similarities to CA in jawbone location, tumor size, and radiology. The recurrence rate of classic DA (9.2%) was lower than that of CA (25.8%).

Conclusion

High anterior‐premolar distribution, a mixture of osteolytic and internal high‐density shadows in radiology, smaller tumor size, compressed epithelium with abundant stroma and scattered bone, consistent mutation of BRAF V600E , and better prognosis all suggest that classic DA may be a distinct clinicopathological subtype of ameloblastoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmeloblastomaMandibular NeoplasmsJaw NeoplasmsHumansMaleFemaleAdultMiddle Agedbeta CateninProto-Oncogene Proteins B-rafMutationAdolescentYoung AdultAgedImmunohistochemistry

Stichwörter der Autor:innen

BRAF V600ECTNNB1SMO L412Fclassicdesmoplastic/conventional ameloblastomahybrid

Substanzen

beta CateninProto-Oncogene Proteins B-rafCTNNB1 protein, humanBRAF protein, human

Autor:innen und Institutionen

  • Department of Oral Pathology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • National Center for Stomatology, Shanghai, China.
  • National Clinical Research Center for Oral Diseases, Shanghai, China.
  • Shanghai Key Laboratory of Stomatology, Shanghai, China.
  • Shanghai Research Institute of Stomatology, Shanghai, China.
  • Department of Radiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Ronghui Xia, Liam Robinson, Willie van Heerden, Wanninayake Mudiyanselage Tilakaratne, Kelly Magliocca, Merva Soluk-Tekkesin, Akinyele Olumuyiwa Adisa, Elizabeth Ann Bilodeau, Haizal Mohd Hussaini, Ronell Bologna-Molina, Ricardo Santiago Gomez, Keith David Hunter, Jiang Li

Förderung

  • Shanghai's Top Priority Research Center
  • Cross-research Fund Project of Shanghai Ninth People's Hospital and Shanghai University of Science and Technology
  • National Clinical Medical Research Center for Oral Diseases (Shanghai Ninth Hospital)

Zitieren

APA

Zheng, X., Xia, R., Zhu, W., Qu, C., Gu, T., Robinson, L., van Heerden, W., Tilakaratne, W. M., Magliocca, K., Soluk-Tekkesin, M., Adisa, A. O., Bilodeau, E. A., Hussaini, H. M., Bologna-Molina, R., Gomez, R. S., Hunter, K. D., & Li, J. (2025). Classic Desmoplastic Ameloblastoma: Should It Be a Distinct Subtype of Ameloblastoma?—Based on Clinicopathological, Radiological, Immunohistochemical and Molecular Study of a Large Cohort. Oral Diseases. https://doi.org/10.1111/odi.15376

Vancouver

Zheng X, Xia R, Zhu W, Qu C, Gu T, Robinson L, et al. Classic Desmoplastic Ameloblastoma: Should It Be a Distinct Subtype of Ameloblastoma?—Based on Clinicopathological, Radiological, Immunohistochemical and Molecular Study of a Large Cohort. Oral Diseases. 2025. doi:10.1111/odi.15376

BibTeX
@article{Zheng2025,
  author = {Zheng, Xiaofeng and Xia, Ronghui and Zhu, Wenjing and Qu, Chuxiang and Gu, Ting and Robinson, Liam and van Heerden, Willie and Tilakaratne, Wanninayake Mudiyanselage and Magliocca, Kelly and Soluk-Tekkesin, Merva and Adisa, Akinyele Olumuyiwa and Bilodeau, Elizabeth Ann and Hussaini, Haizal Mohd and Bologna-Molina, Ronell and Gomez, Ricardo Santiago and Hunter, Keith David and Li, Jiang},
  title = {Classic Desmoplastic Ameloblastoma: Should It Be a Distinct Subtype of Ameloblastoma?—Based on Clinicopathological, Radiological, Immunohistochemical and Molecular Study of a Large Cohort},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.15376}
}
Kostenlos starten →